tiprankstipranks
Advertisement
Advertisement

NUVL Stock Latest News

Nuvalent: Buy Rating on Strong Pipeline Execution, Dual NDA Momentum, and Solid Cash Runway in Targeted NSCLC
RatingsNuvalent: Buy Rating on Strong Pipeline Execution, Dual NDA Momentum, and Solid Cash Runway in Targeted NSCLC
8d ago
NUVL
Nuvalent Files FDA Application for Lung Cancer Therapy
PremiumCompany Announcements
Nuvalent Files FDA Application for Lung Cancer Therapy
8d ago
8K
NUVL
Nuvalent submits neladalkib NDA to FDA
PremiumThe Fly
Nuvalent submits neladalkib NDA to FDA
8d ago
NUVL
Nuvalent initiated with an Overweight at Wells Fargo
PremiumThe Fly
Nuvalent initiated with an Overweight at Wells Fargo
17d ago
NUVL
De-Risked Oncology Pipeline and Strong Cash Position Underpin Outperform Rating and $125 Target
PremiumRatings
De-Risked Oncology Pipeline and Strong Cash Position Underpin Outperform Rating and $125 Target
1M ago
NUVL
Nuvalent price target raised to $138 from $132 at UBS
PremiumThe FlyNuvalent price target raised to $138 from $132 at UBS
1M ago
NUVL
Nuvalent: Buy Rating Backed by Late‑Stage Oncology Pipeline and Upcoming Value‑Driving Milestones
Premium
Ratings
Nuvalent: Buy Rating Backed by Late‑Stage Oncology Pipeline and Upcoming Value‑Driving Milestones
1M ago
NUVL
Nuvalent price target raised to $140 from $135 at Cantor Fitzgerald
Premium
The Fly
Nuvalent price target raised to $140 from $135 at Cantor Fitzgerald
2M ago
NUVL
Nuvalent reports Q4 EPS ($1.58), consensus ($1.44)
PremiumThe Fly
Nuvalent reports Q4 EPS ($1.58), consensus ($1.44)
2M ago
NUVL
Nuvalent files automatic mixed securities shelf
PremiumThe Fly
Nuvalent files automatic mixed securities shelf
4M ago
NUVL
Nuvalent price target lowered to $145 from $147 at JPMorgan
PremiumThe Fly
Nuvalent price target lowered to $145 from $147 at JPMorgan
4M ago
NUVL
3 ‘Strong Buy’ Stocks to Buy Today, 12/18/2025, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Today, 12/18/2025, According to Top Analysts
4M ago
FHTX
NUVL
Nuvalent’s Royalty Interest Acquired by Royalty Pharma
PremiumCompany AnnouncementsNuvalent’s Royalty Interest Acquired by Royalty Pharma
4M ago
8K
NUVL
Royalty Pharma acquires royalty interest in Nuvalent’s neladalkib, zidesamtinib
Premium
The Fly
Royalty Pharma acquires royalty interest in Nuvalent’s neladalkib, zidesamtinib
4M ago
NUVL
RPRX
Ron Squarer Joins Nuvalent Board as Independent Director
Premium
Company Announcements
Ron Squarer Joins Nuvalent Board as Independent Director
4M ago
8K
NUVL
Nuvalent initiated with a Buy at Truist
PremiumThe Fly
Nuvalent initiated with a Buy at Truist
5M ago
NUVL
Nuvalent Announces $500M Stock Offering Pricing
PremiumCompany Announcements
Nuvalent Announces $500M Stock Offering Pricing
5M ago
8K
NUVL
Nuvalent’s New Drug Application for zidesamtinib in NSCLC acepted by FDA
PremiumThe Fly
Nuvalent’s New Drug Application for zidesamtinib in NSCLC acepted by FDA
5M ago
NUVL
Nuvalent 4.95M share Secondary priced at $101.00
PremiumThe Fly
Nuvalent 4.95M share Secondary priced at $101.00
5M ago
NUVL
Nuvalent price target raised to $135 from $120 at Goldman Sachs
PremiumThe FlyNuvalent price target raised to $135 from $120 at Goldman Sachs
5M ago
NUVL
Nuvalent price target raised to $155 from $125 at Guggenheim
Premium
The Fly
Nuvalent price target raised to $155 from $125 at Guggenheim
5M ago
NUVL
Nuvalent price target raised to $158 from $112 at Baird
Premium
The Fly
Nuvalent price target raised to $158 from $112 at Baird
5M ago
NUVL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >